DENTSPLY SIRONA (XRAY) Financials

$12.55 -0.53 (-4.05%)

Closing price 04:00 PM Eastern

Extended Trading

$12.63 +0.08 (+0.63%)

As of 07:55 PM Eastern

Annual Income Statements for DENTSPLY SIRONA

This table shows DENTSPLY SIRONA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	251	430	-1,550	-1,011	256	-73	411	-950	-132	-910
Consolidated Net Income / (Loss)	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910
Net Income / (Loss) Continuing Operations	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910
Total Pre-Tax Income	330	441	-1,604	-958	338	-50	545	-1,055	-175	-936
Total Operating Income	375	455	-1,562	-958	353	-3.00	608	-937	-85	-879
Total Gross Profit	1,517	2,001	2,189	2,068	2,164	1,656	2,347	2,127	2,086	1,958
Total Revenue	2,674	3,745	3,993	3,986	4,022	3,339	4,231	3,922	3,965	3,793
Operating Revenue	2,674	3,745	3,993	3,986	4,022	3,339	4,231	3,922	3,965	3,793
Total Cost of Revenue	1,157	1,744	1,805	1,918	1,858	1,683	1,884	1,795	1,879	1,835
Operating Cost of Revenue	1,157	1,744	1,805	1,918	1,858	1,683	1,884	1,795	1,879	1,835
Total Operating Expenses	1,142	1,546	3,751	3,026	1,811	1,659	1,739	3,064	2,171	2,837
Selling, General & Admin Expense	1,077	1,523	1,675	1,719	1,587	1,302	1,551	1,589	1,613	1,605
Research & Development Expense	-	-	-	-	143	123	171	174	184	165
Impairment Charge	0.00	0.00	1,651	1,086	0.00	234	0.00	1,287	307	1,014
Restructuring Charge	65	23	425	221	81	-	17	14	67	53
Total Other Income / (Expense), net	-46	-14	-41	0.00	-15	-47	-63	-118	-90	-57
Interest Expense	56	36	38	37	-	-	61	65	81	69
Other Income / (Expense), net	8.20	20	-5.30	35	12	-1.00	-2.00	-53	-9.00	12
Income Tax Expense	77	9.50	-53	53	82	23	134	-105	-43	-26
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.10	1.50	-0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basic Earnings per Share	$1.79	$1.97	($6.76)	($4.51)	$1.15	($0.33)	$1.88	($4.41)	($0.62)	($4.48)
Weighted Average Basic Shares Outstanding	140M	218M	229.40M	224.30M	223.10M	219.20M	218.40M	215.50M	212M	203.20M
Diluted Earnings per Share	$1.76	$1.94	($6.76)	($4.51)	$1.14	($0.33)	$1.87	($4.41)	($0.62)	($4.48)
Weighted Average Diluted Shares Outstanding	142.70M	221.60M	229.40M	224.30M	224.40M	219.20M	220.20M	215.50M	212M	203.20M
Weighted Average Basic & Diluted Shares Outstanding	140.30M	218.20M	229.30M	224.20M	221.44M	219.05M	217.55M	215.36M	207.36M	198.99M
Cash Dividends to Common per Share	$0.29	$0.31	$0.35	$0.35	$0.38	$0.40	$0.43	$0.50	$0.56	$0.64

This table shows DENTSPLY SIRONA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-1,077	-15	-19	86	-266	67	18	-4.00	-494	-430
Consolidated Net Income / (Loss)	-1,077	-15	-23	85	-266	72	17	-4.00	-495	-428
Net Income / (Loss) Continuing Operations	-1,077	-15	-23	85	-266	72	17	-4.00	-495	-428
Total Pre-Tax Income	-1,241	8.00	-28	46	-250	57	31	34	-478	-523
Total Operating Income	-1,218	65	-2.00	80	-236	73	42	50	-462	-509
Total Gross Profit	508	517	519	550	495	522	506	511	495	446
Total Revenue	947	983	978	1,028	947	1,012	953	984	951	905
Operating Revenue	947	983	978	1,028	947	1,012	953	984	951	905
Total Cost of Revenue	439	466	459	478	452	490	447	473	456	459
Operating Cost of Revenue	439	466	459	478	452	490	447	473	456	459
Total Operating Expenses	1,726	452	521	470	731	449	464	461	957	955
Selling, General & Admin Expense	401	402	416	416	372	409	415	399	390	401
Research & Development Expense	41	43	46	49	46	43	42	41	40	42
Impairment Charge	1,281	-	0.00	0.00	307	-	6.00	0.00	504	504
Restructuring Charge	3.00	1.00	59	5.00	6.00	-3.00	1.00	21	23	8.00
Total Other Income / (Expense), net	-23	-57	-26	-34	-14	-16	-11	-16	-16	-14
Interest Expense	14	24	20	22	19	20	18	17	18	16
Other Income / (Expense), net	-9.00	-33	-6.00	-12	5.00	4.00	7.00	1.00	2.00	2.00
Income Tax Expense	-164	23	-5.00	-39	16	-15	14	38	17	-95
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	-4.00	-1.00	0.00	5.00	-1.00	0.00	-1.00	2.00
Basic Earnings per Share	($5.01)	($0.06)	($0.09)	$0.41	($1.25)	$0.31	$0.09	($0.02)	($2.46)	($2.09)
Weighted Average Basic Shares Outstanding	214.90M	215.50M	214.50M	211.90M	211.80M	212M	207.40M	205.60M	201M	203.20M
Diluted Earnings per Share	($5.01)	($0.06)	($0.09)	$0.40	($1.25)	$0.32	$0.09	($0.02)	($2.46)	($2.09)
Weighted Average Diluted Shares Outstanding	214.90M	215.50M	214.50M	213.10M	211.80M	212M	208.50M	205.60M	201M	203.20M
Weighted Average Basic & Diluted Shares Outstanding	214.91M	215.36M	212.48M	211.72M	211.86M	207.36M	207.63M	202.71M	198.78M	198.99M

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	133	99	-63	-3.00	95	33	-99	26	-31	-62
Net Cash From Operating Activities	497	563	602	500	639	649	657	517	377	461
Net Cash From Continuing Operating Activities	497	563	602	500	639	649	657	517	377	461
Net Income / (Loss) Continuing Operations	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910
Consolidated Net Income / (Loss)	251	431	-1,550	-1,011	256	-73	411	-950	-132	-910
Depreciation Expense	79	117	127	133	133	142	124	119	132	133
Amortization Expense	55	160	192	201	190	192	222	209	211	216
Non-Cash Adjustments To Reconcile Net Income	47	9.10	2,122	1,273	116	250	51	1,445	352	1,063
Changes in Operating Assets and Liabilities, net	66	-153	-289	-96	-56	138	-151	-306	-186	-41
Net Cash From Investing Activities	-55	60	-286	-253	-69	-1,106	-358	-138	-89	-197
Net Cash From Continuing Investing Activities	-55	60	-286	-253	-69	-1,106	-358	-138	-89	-197
Purchase of Property, Plant & Equipment	-72	-125	-144	-183	-123	-87	-142	-149	-149	-180
Purchase of Investments	-6.30	-24	-2.50	-6.00	-	-	-	0.00	0.00	-12
Divestitures	0.00	528	0.00	0.00	11	1.00	28	0.00	13	0.00
Sale and/or Maturity of Investments	78	20	6.50	62	40	58	2.00	13	39	1.00
Other Investing Activities, net	-1.40	-1.70	-0.90	-	6.00	0.00	2.00	-2.00	8.00	-6.00
Net Cash From Financing Activities	-303	-526	-401	-250	-472	476	-379	-329	-307	-302
Net Cash From Continuing Financing Activities	-303	-526	-401	-250	-472	476	-379	-329	-307	-302
Repayment of Debt	-270	-922	-17	-9.00	-360	-727	-154	-81	-17	-104
Repurchase of Common Equity	-113	-814	-401	-250	-260	-140	-200	-150	-300	-250
Payment of Dividends	-40	-65	-78	-79	-81	-88	-92	-104	-116	-126
Issuance of Debt	153	1,221	13	60	120	1,450	16	6.00	126	178
Effect of Exchange Rate Changes	-6.60	2.10	-	-	-3.00	-	-19	-24	-	-24
Cash Interest Paid	55	37	37	35	30	45	64	70	97	91
Cash Income Taxes Paid	71	112	123	105	112	82	148	122	177	74

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	56	-53	-47	-23	14	25	-43	-12	17	-24
Net Cash From Operating Activities	109	142	-21	104	134	160	25	208	141	87
Net Cash From Continuing Operating Activities	109	142	-21	104	134	160	25	208	141	87
Net Income / (Loss) Continuing Operations	-1,077	-15	-23	85	-266	72	17	-4.00	-495	-428
Consolidated Net Income / (Loss)	-1,077	-15	-23	85	-266	72	17	-4.00	-495	-428
Depreciation Expense	31	29	31	33	35	33	32	32	35	34
Amortization Expense	51	50	53	53	53	52	54	54	54	54
Non-Cash Adjustments To Reconcile Net Income	1,302	84	78	-11	302	-17	36	31	514	482
Changes in Operating Assets and Liabilities, net	-198	-6.00	-160	-56	10	20	-114	95	33	-55
Net Cash From Investing Activities	-26	-29	-37	-30	-2.00	-20	-43	-50	-47	-57
Net Cash From Continuing Investing Activities	-26	-29	-37	-30	-2.00	-20	-43	-50	-47	-57
Purchase of Property, Plant & Equipment	-32	-32	-39	-33	-37	-40	-34	-52	-43	-51
Sale and/or Maturity of Investments	5.00	3.00	2.00	2.00	35	-	0.00	1.00	-1.00	1.00
Other Investing Activities, net	1.00	-	-	-	-	7.00	-	-	-	-7.00
Net Cash From Financing Activities	-6.00	-161	17	-87	-109	-128	-14	-171	-79	-38
Net Cash From Continuing Financing Activities	-6.00	-161	17	-87	-109	-128	-14	-171	-79	-38
Repayment of Debt	-7.00	-64	-4.00	-2.00	-7.00	-4.00	-8.00	-8.00	-2.00	-86
Payment of Dividends	-27	-26	-27	-30	-29	-30	-29	-33	-33	-31
Issuance of Debt	28	-65	198	-55	-73	56	23	20	56	79
Effect of Exchange Rate Changes	-	-	-	-	-9.00	-	-11	1.00	2.00	-16

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	4,403	11,556	10,375	8,687	8,603	9,350	9,239	7,643	7,370	5,753
Total Current Assets	1,197	1,744	2,003	1,888	2,000	1,798	1,852	1,893	1,973	1,746
Cash & Equivalents	285	384	321	310	405	438	339	365	334	272
Note & Lease Receivable	400	636	746	702	782	667	750	632	695	556
Inventories, net	340	517	623	599	562	476	515	627	624	564
Prepaid Expenses	172	207	313	278	251	217	248	269	320	354
Plant, Property, & Equipment, net	559	800	876	871	802	791	773	761	800	766
Total Noncurrent Assets	2,647	9,013	7,496	5,928	5,801	6,761	6,614	4,989	4,597	3,241
Goodwill	1,988	5,952	4,539	3,431	3,397	3,986	3,976	2,688	2,438	1,597
Intangible Assets	601	2,958	2,801	2,420	2,176	2,504	2,319	1,903	1,705	1,207
Other Noncurrent Operating Assets	59	103	156	77	228	271	319	398	454	437
Total Liabilities & Shareholders' Equity	4,403	11,556	10,375	8,687	8,603	9,350	9,239	7,643	7,370	5,753
Total Liabilities	2,064	3,430	3,747	3,554	3,508	4,415	4,242	3,831	4,076	3,810
Total Current Liabilities	476	768	955	1,013	995	1,372	1,261	1,170	1,425	1,589
Short-Term Debt	12	21	30	92	2.00	299	182	118	322	549
Accounts Payable	134	223	284	284	308	302	262	279	305	241
Accrued Expenses	310	463	586	579	629	712	760	727	749	754
Current Deferred & Payable Income Tax Liabilities	20	61	54	58	56	59	57	46	49	45
Total Noncurrent Liabilities	1,588	2,662	2,792	2,541	2,513	3,043	2,981	2,661	2,651	2,221
Long-Term Debt	1,141	1,511	1,612	1,565	1,433	1,978	1,913	1,826	1,796	1,586
Noncurrent Deferred & Payable Income Tax Liabilities	160	752	718	553	480	381	391	287	228	129
Other Noncurrent Operating Liabilities	286	400	463	423	600	684	677	548	627	506
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,339	8,126	6,628	5,133	5,095	4,935	4,997	3,812	3,294	1,943
Total Preferred & Common Equity	2,338	8,114	6,616	5,121	5,093	4,932	4,996	3,811	3,293	1,942
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,338	8,114	6,616	5,121	5,093	4,932	4,996	3,811	3,293	1,942
Common Stock	239	6,519	6,547	6,525	6,590	6,607	6,609	6,632	6,646	6,643
Retained Earnings	3,591	3,948	2,316	1,226	1,404	1,198	1,514	456	205	-835
Treasury Stock	-898	-1,647	-1,955	-2,151	-2,301	-2,409	-2,535	-2,649	-2,922	-3,136
Accumulated Other Comprehensive Income / (Loss)	-594	-706	-291	-479	-600	-464	-592	-628	-636	-730
Noncontrolling Interest	1.40	12	12	12	2.00	3.00	1.00	1.00	1.00	1.00

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	7,522	7,673	7,650	7,201	7,123	6,897	6,626
Total Current Assets	1,939	1,943	1,920	1,913	1,902	1,758	1,921
Cash & Equivalents	418	318	295	309	291	279	296
Note & Lease Receivable	645	652	670	649	656	591	671
Inventories, net	592	659	657	651	613	608	619
Prepaid Expenses	284	314	298	304	342	280	335
Plant, Property, & Equipment, net	714	770	772	753	782	789	817
Total Noncurrent Assets	4,869	4,960	4,958	4,535	4,439	4,350	3,888
Goodwill	2,584	2,701	2,703	2,374	2,400	2,389	1,937
Intangible Assets	1,875	1,862	1,808	1,711	1,618	1,559	1,538
Other Noncurrent Operating Assets	410	397	447	450	421	402	413
Total Liabilities & Shareholders' Equity	7,522	7,673	7,650	7,201	7,123	6,897	6,626
Total Liabilities	3,908	4,035	3,948	3,830	3,865	3,833	4,136
Total Current Liabilities	1,296	1,374	1,271	1,218	1,330	1,323	1,542
Short-Term Debt	246	316	261	187	343	362	422
Accounts Payable	271	267	265	262	279	287	297
Accrued Expenses	711	748	728	732	681	650	798
Current Deferred & Payable Income Tax Liabilities	68	43	17	37	27	24	25
Total Noncurrent Liabilities	2,612	2,661	2,677	2,612	2,535	2,510	2,594
Long-Term Debt	1,737	1,842	1,841	1,803	1,747	1,737	1,795
Noncurrent Deferred & Payable Income Tax Liabilities	246	271	261	249	214	194	193
Other Noncurrent Operating Liabilities	629	548	575	560	574	579	606
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,614	3,638	3,702	3,371	3,258	3,064	2,490
Total Preferred & Common Equity	3,613	3,641	3,706	3,375	3,258	3,064	2,491
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,613	3,641	3,706	3,375	3,258	3,064	2,491
Common Stock	6,622	6,607	6,651	6,648	6,642	6,634	6,642
Retained Earnings	498	407	463	167	190	152	-374
Treasury Stock	-2,663	-2,759	-2,788	-2,783	-2,908	-3,045	-3,139
Accumulated Other Comprehensive Income / (Loss)	-844	-614	-620	-657	-666	-677	-638
Noncontrolling Interest	1.00	-3.00	-4.00	-4.00	0.00	0.00	-1.00

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.50%	40.05%	6.62%	-0.19%	0.90%	-16.98%	26.71%	-7.30%	1.10%	-4.34%
EBITDA Growth	-10.67%	45.09%	-266.26%	52.83%	216.81%	-52.03%	188.48%	-169.54%	137.61%	-308.03%
EBIT Growth	-13.98%	23.84%	-430.16%	41.12%	139.55%	-101.10%	15,250.00%	-263.37%	90.51%	-822.34%
NOPAT Growth	-19.27%	54.71%	-345.81%	38.68%	139.87%	-100.79%	21,933.81%	-243.05%	90.93%	-934.12%
Net Income Growth	-22.24%	71.80%	-459.36%	34.79%	125.32%	-128.52%	663.01%	-331.14%	86.11%	-589.39%
EPS Growth	-21.43%	10.23%	-448.45%	33.28%	125.28%	-128.95%	666.67%	-335.83%	85.94%	-622.58%
Operating Cash Flow Growth	-11.24%	13.27%	6.83%	-16.93%	27.80%	1.56%	1.23%	-21.31%	-27.08%	22.28%
Free Cash Flow Firm Growth	-43.27%	-1,197.56%	104.12%	244.44%	-21.89%	-204.50%	173.65%	47.25%	-64.10%	159.05%
Invested Capital Growth	-6.54%	189.11%	-14.29%	-18.47%	-5.49%	10.60%	-0.31%	-20.17%	-5.81%	-25.05%
Revenue Q/Q Growth	-1.76%	9.51%	2.42%	-0.79%	1.13%	-0.40%	0.28%	-2.97%	0.74%	-2.74%
EBITDA Q/Q Growth	-0.32%	12.34%	-204.09%	57.19%	7.35%	10.55%	1.60%	-28.79%	25.76%	-922.22%
EBIT Q/Q Growth	-1.92%	10.03%	-116.94%	46.13%	15.73%	83.94%	2.89%	-16.75%	32.37%	-206.36%
NOPAT Q/Q Growth	-5.32%	7.15%	-116.48%	45.14%	53.99%	89.40%	1.58%	-12.89%	8.60%	-195.96%
Net Income Q/Q Growth	-9.40%	12.90%	-95.70%	39.19%	58.02%	21.17%	0.98%	-16.42%	39.73%	-121.95%
EPS Q/Q Growth	-9.74%	0.00%	-92.05%	38.47%	62.86%	21.43%	1.63%	-16.05%	38.00%	-116.43%
Operating Cash Flow Q/Q Growth	-11.76%	20.54%	1.09%	-5.03%	19.24%	-6.01%	-6.01%	-13.40%	5.01%	-13.67%
Free Cash Flow Firm Q/Q Growth	-34.58%	6.27%	-36.64%	-8.17%	8.20%	-227.07%	169.47%	-35.69%	309.53%	51.63%
Invested Capital Q/Q Growth	0.24%	-3.52%	-9.07%	-2.56%	-1.98%	18.50%	-1.53%	4.09%	0.51%	-13.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.73%	53.42%	54.80%	51.88%	53.80%	49.60%	55.47%	54.23%	52.61%	51.62%
EBITDA Margin	19.35%	20.05%	-31.27%	-14.78%	17.11%	9.88%	22.50%	-16.88%	6.28%	-13.66%
Operating Margin	14.03%	12.14%	-39.12%	-24.03%	8.78%	-0.09%	14.37%	-23.89%	-2.14%	-23.17%
EBIT Margin	14.34%	12.68%	-39.25%	-23.16%	9.08%	-0.12%	14.32%	-25.24%	-2.37%	-22.86%
Profit (Net Income) Margin	9.39%	11.52%	-38.82%	-25.36%	6.37%	-2.19%	9.71%	-24.22%	-3.33%	-23.99%
Tax Burden Percent	76.16%	97.85%	96.68%	105.53%	75.74%	146.00%	75.41%	90.05%	75.43%	97.22%
Interest Burden Percent	85.99%	92.86%	102.29%	103.79%	92.60%	1,250.00%	89.93%	106.57%	186.17%	107.96%
Effective Tax Rate	23.35%	2.15%	0.00%	0.00%	24.26%	0.00%	24.59%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	8.66%	7.13%	-12.70%	-9.29%	4.24%	-0.03%	6.78%	-10.80%	-1.14%	-13.85%
ROIC Less NNEP Spread (ROIC-NNEP)	4.97%	5.79%	-49.69%	-34.80%	3.29%	-4.98%	4.14%	-28.44%	-5.45%	-30.01%
Return on Net Nonoperating Assets (RNNOA)	2.11%	1.12%	-8.32%	-7.90%	0.76%	-1.42%	1.50%	-10.77%	-2.58%	-20.90%
Return on Equity (ROE)	10.77%	8.24%	-21.02%	-17.19%	5.01%	-1.46%	8.28%	-21.57%	-3.72%	-34.75%
Cash Return on Invested Capital (CROIC)	15.43%	-90.07%	2.69%	11.06%	9.89%	-10.10%	7.09%	11.63%	4.84%	14.78%
Operating Return on Assets (OROA)	8.47%	5.95%	-14.30%	-9.68%	4.22%	-0.04%	6.52%	-11.73%	-1.25%	-13.21%
Return on Assets (ROA)	5.55%	5.41%	-14.14%	-10.61%	2.96%	-0.81%	4.42%	-11.25%	-1.76%	-13.87%
Return on Common Equity (ROCE)	10.77%	8.23%	-20.98%	-17.16%	5.00%	-1.45%	8.27%	-21.56%	-3.71%	-34.74%
Return on Equity Simple (ROE_SIMPLE)	10.74%	5.32%	-23.43%	-19.74%	5.03%	-1.48%	8.23%	-24.93%	-4.01%	-46.86%
Net Operating Profit after Tax (NOPAT)	288	445	-1,094	-671	267	-2.10	459	-656	-60	-615
NOPAT Margin	10.75%	11.88%	-27.39%	-16.82%	6.65%	-0.06%	10.84%	-16.72%	-1.50%	-16.22%
Net Nonoperating Expense Percent (NNEP)	3.69%	1.34%	36.99%	25.51%	0.96%	4.94%	2.64%	17.64%	4.31%	16.16%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-11.40%	-1.10%	-15.09%
Cost of Revenue to Revenue	43.27%	46.58%	45.20%	48.12%	46.20%	50.40%	44.53%	45.77%	47.39%	48.38%
SG&A Expenses to Revenue	40.28%	40.66%	41.94%	43.13%	39.46%	38.99%	36.66%	40.52%	40.68%	42.31%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	3.56%	3.68%	4.04%	4.44%	4.64%	4.35%
Operating Expenses to Revenue	42.70%	41.28%	93.93%	75.92%	45.03%	49.69%	41.10%	78.12%	54.75%	74.80%
Earnings before Interest and Taxes (EBIT)	383	475	-1,568	-923	365	-4.00	606	-990	-94	-867
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	518	751	-1,249	-589	688	330	952	-662	249	-518
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.35	1.52	2.12	1.52	2.33	2.21	2.34	1.72	2.23	1.94
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.93	3.29	3.52	1.95	2.95	3.27	2.77	1.67	1.85	0.99
Price to Earnings (P/E)	31.17	28.67	0.00	0.00	46.42	0.00	28.49	0.00	0.00	0.00
Dividend Yield	0.52%	0.58%	0.57%	1.00%	0.70%	0.80%	0.80%	1.64%	1.61%	3.37%
Earnings Yield	3.21%	3.49%	0.00%	0.00%	2.15%	0.00%	3.51%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.71	1.45	1.94	1.41	2.11	1.88	1.99	1.51	1.80	1.48
Enterprise Value to Revenue (EV/Rev)	3.25	3.60	3.85	2.29	3.21	3.82	3.18	2.08	2.30	1.49
Enterprise Value to EBITDA (EV/EBITDA)	16.81	17.95	0.00	0.00	18.77	38.63	14.14	0.00	36.68	0.00
Enterprise Value to EBIT (EV/EBIT)	22.69	28.40	0.00	0.00	35.38	0.00	22.22	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	30.25	30.31	0.00	0.00	48.30	0.00	29.37	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.49	23.93	25.57	18.25	20.21	19.64	20.49	15.76	24.23	12.23
Enterprise Value to Free Cash Flow (EV/FCFF)	16.98	0.00	66.45	11.44	20.73	0.00	28.08	11.54	36.03	8.58
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.49	0.19	0.25	0.32	0.28	0.46	0.42	0.51	0.64	1.10
Long-Term Debt to Equity	0.49	0.19	0.24	0.30	0.28	0.40	0.38	0.48	0.55	0.82
Financial Leverage	0.42	0.19	0.17	0.23	0.23	0.29	0.36	0.38	0.47	0.70
Leverage Ratio	1.94	1.52	1.49	1.62	1.69	1.79	1.87	1.92	2.11	2.51
Compound Leverage Factor	1.67	1.42	1.52	1.68	1.57	22.37	1.68	2.04	3.93	2.71
Debt to Total Capital	33.02%	15.86%	19.85%	24.41%	21.98%	31.57%	29.54%	33.77%	39.14%	52.35%
Short-Term Debt to Total Capital	0.35%	0.22%	0.36%	1.36%	0.03%	4.15%	2.57%	2.05%	5.95%	13.46%
Long-Term Debt to Total Capital	32.67%	15.65%	19.49%	23.05%	21.94%	27.43%	26.97%	31.72%	33.19%	38.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.12%	0.14%	0.18%	0.03%	0.04%	0.01%	0.02%	0.02%	0.02%
Common Equity to Total Capital	66.94%	84.02%	80.01%	75.42%	77.99%	68.39%	70.45%	66.21%	60.85%	47.62%
Debt to EBITDA	2.23	2.04	-1.31	-2.81	2.09	6.90	2.20	-2.94	8.51	-4.12
Net Debt to EBITDA	1.68	1.53	-1.06	-2.29	1.50	5.57	1.84	-2.39	7.16	-3.60
Long-Term Debt to EBITDA	2.20	2.01	-1.29	-2.66	2.08	5.99	2.01	-2.76	7.21	-3.06
Debt to NOPAT	4.01	3.44	-1.50	-2.47	5.37	-1,084.29	4.57	-2.96	-35.60	-3.47
Net Debt to NOPAT	3.02	2.58	-1.21	-2.01	3.85	-875.71	3.83	-2.41	-29.98	-3.03
Long-Term Debt to NOPAT	3.97	3.40	-1.47	-2.33	5.36	-941.90	4.17	-2.78	-30.18	-2.58
Altman Z-Score	4.51	3.20	2.57	1.74	3.01	2.07	2.64	1.31	1.71	0.59
Noncontrolling Interest Sharing Ratio	0.05%	0.12%	0.16%	0.20%	0.14%	0.05%	0.04%	0.02%	0.03%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.51	2.27	2.10	1.86	2.01	1.31	1.47	1.62	1.38	1.10
Quick Ratio	1.44	1.33	1.12	1.00	1.19	0.81	0.86	0.85	0.72	0.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	512	-5,621	232	798	623	-651	480	706	254	657
Operating Cash Flow to CapEx	694.69%	469.50%	439.66%	287.36%	519.51%	745.98%	462.68%	346.98%	253.02%	256.11%
Free Cash Flow to Firm to Interest Expense	9.16	-156.58	6.05	21.56	0.00	0.00	7.86	10.86	3.13	9.52
Operating Cash Flow to Interest Expense	8.90	15.69	15.72	13.51	0.00	0.00	10.77	7.95	4.65	6.68
Operating Cash Flow Less CapEx to Interest Expense	7.62	12.35	12.14	8.81	0.00	0.00	8.44	5.66	2.81	4.07
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.47	0.36	0.42	0.47	0.37	0.46	0.46	0.53	0.58
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.18	4.07	3.17	3.14	3.20	3.24	3.80	3.14	3.00	3.09
Fixed Asset Turnover	4.66	5.51	4.77	4.56	4.81	4.19	5.41	5.11	5.08	4.84
Accounts Payable Turnover	8.69	9.78	7.11	6.75	6.28	5.52	6.68	6.64	6.43	6.72
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	114.74	89.71	115.29	116.27	114.03	112.56	96.00	116.11	121.50	118.15
Days Payable Outstanding (DPO)	41.99	37.31	51.31	54.07	58.14	66.15	54.63	55.00	56.72	54.30
Cash Conversion Cycle (CCC)	72.76	52.40	63.98	62.20	55.89	46.41	41.36	61.10	64.78	63.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,208	9,274	7,949	6,481	6,125	6,774	6,753	5,391	5,078	3,806
Invested Capital Turnover	0.81	0.60	0.46	0.55	0.64	0.52	0.63	0.65	0.76	0.85
Increase / (Decrease) in Invested Capital	-225	6,066	-1,325	-1,468	-356	649	-21	-1,362	-313	-1,272
Enterprise Value (EV)	8,699	13,484	15,390	9,124	12,915	12,749	13,464	8,148	9,134	5,637
Market Capitalization	7,829	12,324	14,058	7,764	11,883	10,907	11,707	6,568	7,349	3,773
Book Value per Share	$16.72	$35.15	$28.81	$23.01	$22.90	$22.57	$22.85	$17.73	$15.54	$9.77
Tangible Book Value per Share	($1.79)	($3.44)	($3.15)	($3.28)	($2.16)	($7.13)	($5.94)	($3.63)	($4.01)	($4.34)
Total Capital	3,493	9,658	8,270	6,790	6,530	7,212	7,092	5,756	5,412	4,078
Total Debt	1,153	1,532	1,642	1,657	1,435	2,277	2,095	1,944	2,118	2,135
Total Long-Term Debt	1,141	1,511	1,612	1,565	1,433	1,978	1,913	1,826	1,796	1,586
Net Debt	869	1,148	1,321	1,348	1,030	1,839	1,756	1,579	1,784	1,863
Capital Expenditures (CapEx)	72	120	137	174	123	87	142	149	149	180
Debt-free, Cash-free Net Working Capital (DFCFNWC)	448	613	758	658	602	287	434	476	536	434
Debt-free Net Working Capital (DFNWC)	733	997	1,078	967	1,007	725	773	841	870	706
Net Working Capital (NWC)	721	976	1,048	875	1,005	426	591	723	548	157
Net Nonoperating Expense (NNE)	36	14	457	340	11	71	48	294	73	295
Net Nonoperating Obligations (NNO)	869	1,148	1,321	1,348	1,030	1,839	1,756	1,579	1,784	1,863
Total Depreciation and Amortization (D&A)	134	276	319	334	323	334	346	328	343	349
Debt-free, Cash-free Net Working Capital to Revenue	16.76%	16.37%	18.97%	16.50%	14.97%	8.60%	10.26%	12.14%	13.52%	11.44%
Debt-free Net Working Capital to Revenue	27.40%	26.62%	27.00%	24.26%	25.04%	21.71%	18.27%	21.44%	21.94%	18.61%
Net Working Capital to Revenue	26.95%	26.06%	26.24%	21.94%	24.99%	12.76%	13.97%	18.43%	13.82%	4.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.79	$1.97	($6.76)	($4.51)	$1.18	($0.38)	$1.93	$0.00	($0.62)	($4.48)
Adjusted Weighted Average Basic Shares Outstanding	140M	218M	229.40M	224.30M	223.10M	219.20M	218.40M	0.00	212M	203.20M
Adjusted Diluted Earnings per Share	$1.76	$1.94	($6.76)	($4.51)	$1.17	($0.38)	$1.91	$0.00	($0.62)	($4.48)
Adjusted Weighted Average Diluted Shares Outstanding	142.50M	221.60M	229.40M	224.30M	224.40M	219.20M	220.20M	0.00	212M	203.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	140.12M	229.68M	227.38M	223.22M	221.44M	219.05M	217.55M	0.00	207.36M	198.99M
Normalized Net Operating Profit after Tax (NOPAT)	337	468	360	244	329	162	471	255	202	132
Normalized NOPAT Margin	12.61%	12.49%	9.01%	6.13%	8.17%	4.84%	11.14%	6.50%	5.10%	3.47%
Pre Tax Income Margin	12.33%	11.77%	-40.15%	-24.03%	8.40%	-1.50%	12.88%	-26.90%	-4.41%	-24.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.86	13.23	-40.93	-24.95	0.00	0.00	9.93	-15.23	-1.16	-12.57
NOPAT to Interest Expense	5.14	12.39	-28.55	-18.12	0.00	0.00	7.52	-10.09	-0.73	-8.92
EBIT Less CapEx to Interest Expense	5.58	9.88	-44.50	-29.65	0.00	0.00	7.61	-17.52	-3.00	-15.17
NOPAT Less CapEx to Interest Expense	3.86	9.05	-32.13	-22.83	0.00	0.00	5.19	-12.38	-2.57	-11.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.93%	14.97%	-5.05%	-7.81%	31.64%	-120.55%	22.38%	-10.95%	-87.88%	-13.85%
Augmented Payout Ratio	60.81%	203.64%	-30.94%	-32.54%	133.20%	-312.33%	71.05%	-26.74%	-315.15%	-41.32%

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.94%	-10.88%	0.93%	0.49%	0.00%	2.95%	-2.56%	-4.28%	0.42%	-10.57%
EBITDA Growth	-640.09%	-57.14%	-58.47%	-18.52%	87.51%	45.95%	77.63%	-11.04%	-159.44%	-358.64%
EBIT Growth	-1,066.14%	-81.61%	-108.08%	-35.85%	81.17%	140.63%	712.50%	-25.00%	-99.13%	-758.44%
NOPAT Growth	-968.90%	-192.89%	-101.82%	54.85%	80.62%	175.66%	1,745.16%	-103.98%	-95.76%	-486.40%
Net Income Growth	-1,382.14%	-112.61%	-133.33%	16.44%	75.30%	580.00%	173.91%	-104.71%	-86.09%	-694.44%
EPS Growth	-1,418.42%	-110.91%	-128.13%	17.65%	75.05%	633.33%	200.00%	-105.00%	-96.80%	-753.13%
Operating Cash Flow Growth	-36.63%	-36.04%	-122.58%	-39.88%	22.94%	12.68%	219.05%	100.00%	5.22%	-45.63%
Free Cash Flow Firm Growth	179.20%	714.77%	432.45%	94.04%	-104.62%	-67.33%	-63.89%	-45.78%	931.41%	125.98%
Invested Capital Growth	-24.48%	-20.17%	-18.35%	-15.29%	-2.45%	-5.81%	-7.69%	-11.35%	-12.69%	-25.05%
Revenue Q/Q Growth	-7.43%	3.80%	-0.51%	5.11%	-7.88%	6.86%	-5.83%	3.25%	-3.35%	-4.84%
EBITDA Q/Q Growth	-705.82%	109.69%	-31.53%	102.63%	-192.86%	213.29%	-17.18%	1.48%	-370.80%	-12.94%
EBIT Q/Q Growth	-1,257.55%	102.61%	-125.00%	950.00%	-439.71%	133.33%	-37.18%	4.08%	-1,001.96%	-10.22%
NOPAT Q/Q Growth	-993.13%	85.71%	98.85%	10,659.01%	-211.75%	155.82%	-75.02%	-125.54%	-5,397.80%	-10.17%
Net Income Q/Q Growth	-1,575.34%	98.61%	-53.33%	469.57%	-412.94%	127.07%	-76.39%	-123.53%	-12,275.00%	13.54%
EPS Q/Q Growth	-1,573.53%	98.80%	-50.00%	544.44%	-412.50%	125.60%	-71.88%	-122.22%	-12,200.00%	15.04%
Operating Cash Flow Q/Q Growth	-36.99%	30.28%	-114.79%	595.24%	28.85%	19.40%	-84.38%	732.00%	-32.21%	-38.30%
Free Cash Flow Firm Q/Q Growth	40.43%	50.06%	-0.85%	-7.14%	-103.35%	1,160.76%	9.58%	39.43%	-48.70%	188.32%
Invested Capital Q/Q Growth	-20.36%	4.09%	1.61%	0.57%	-8.30%	0.51%	-0.41%	-3.42%	-9.68%	-13.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.64%	52.59%	53.07%	53.50%	52.27%	51.58%	53.10%	51.93%	52.05%	49.28%
EBITDA Margin	-120.91%	11.29%	7.77%	14.98%	-15.10%	16.01%	14.17%	13.92%	-39.01%	-46.30%
Operating Margin	-128.62%	6.61%	-0.20%	7.78%	-24.92%	7.21%	4.41%	5.08%	-48.58%	-56.24%
EBIT Margin	-129.57%	3.26%	-0.82%	6.61%	-24.39%	7.61%	5.14%	5.18%	-48.37%	-56.02%
Profit (Net Income) Margin	-113.73%	-1.53%	-2.35%	8.27%	-28.09%	7.11%	1.78%	-0.41%	-52.05%	-47.29%
Tax Burden Percent	86.78%	-187.50%	82.14%	184.78%	106.40%	126.32%	54.84%	-11.76%	103.56%	81.84%
Interest Burden Percent	101.14%	25.00%	350.00%	67.65%	108.23%	74.03%	63.27%	66.67%	103.91%	103.16%
Effective Tax Rate	0.00%	287.50%	0.00%	-84.78%	0.00%	-26.32%	45.16%	111.76%	0.00%	0.00%
Return on Invested Capital (ROIC)	-60.46%	-8.01%	-0.09%	9.42%	-13.42%	6.90%	1.81%	-0.45%	-28.03%	-33.62%
ROIC Less NNEP Spread (ROIC-NNEP)	-73.82%	-1.60%	-1.26%	5.80%	-19.63%	5.70%	1.48%	-0.34%	-37.56%	-37.55%
Return on Net Nonoperating Assets (RNNOA)	-28.59%	-0.61%	-0.55%	2.36%	-9.12%	2.70%	0.78%	-0.18%	-23.08%	-26.15%
Return on Equity (ROE)	-89.05%	-8.61%	-0.64%	11.78%	-22.55%	9.60%	2.59%	-0.63%	-51.11%	-59.77%
Cash Return on Invested Capital (CROIC)	18.24%	11.63%	8.30%	4.02%	1.21%	4.84%	7.45%	11.07%	9.15%	14.78%
Operating Return on Assets (OROA)	-62.31%	1.51%	-0.38%	3.14%	-13.04%	4.02%	2.74%	2.78%	-27.29%	-32.38%
Return on Assets (ROA)	-54.69%	-0.71%	-1.10%	3.92%	-15.02%	3.76%	0.95%	-0.22%	-29.36%	-27.34%
Return on Common Equity (ROCE)	-89.01%	-8.61%	-0.64%	11.79%	-22.56%	9.60%	2.59%	-0.63%	-51.16%	-59.74%
Return on Equity Simple (ROE_SIMPLE)	-22.59%	0.00%	-28.62%	-27.79%	-6.49%	0.00%	-2.82%	-5.91%	-16.46%	0.00%
Net Operating Profit after Tax (NOPAT)	-853	-122	-1.40	148	-165	92	23	-5.88	-323	-356
NOPAT Margin	-90.03%	-12.40%	-0.14%	14.38%	-17.44%	9.11%	2.42%	-0.60%	-34.01%	-39.37%
Net Nonoperating Expense Percent (NNEP)	13.36%	-6.41%	1.17%	3.62%	6.21%	1.20%	0.33%	-0.10%	9.53%	3.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.12%	-	-	-	1.70%	-	-	-	-8.74%
Cost of Revenue to Revenue	46.36%	47.41%	46.93%	46.50%	47.73%	48.42%	46.90%	48.07%	47.95%	50.72%
SG&A Expenses to Revenue	42.34%	40.90%	42.54%	40.47%	39.28%	40.42%	43.55%	40.55%	41.01%	44.31%
R&D to Revenue	4.33%	4.37%	4.70%	4.77%	4.86%	4.25%	4.41%	4.17%	4.21%	4.64%
Operating Expenses to Revenue	182.26%	45.98%	53.27%	45.72%	77.19%	44.37%	48.69%	46.85%	100.63%	105.52%
Earnings before Interest and Taxes (EBIT)	-1,227	32	-8.00	68	-231	77	49	51	-460	-507
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1,145	111	76	154	-143	162	135	137	-371	-419
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.66	1.72	2.27	2.25	2.10	2.23	2.10	1.69	2.20	1.94
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.48	1.67	2.10	2.12	1.80	1.85	1.74	1.33	1.41	0.99
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	1.76%	1.64%	1.34%	1.35%	1.63%	1.61%	1.76%	2.41%	2.29%	3.37%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.46	1.51	1.84	1.84	1.73	1.80	1.71	1.43	1.68	1.48
Enterprise Value to Revenue (EV/Rev)	1.87	2.08	2.57	2.58	2.22	2.30	2.19	1.79	1.90	1.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	44.23	36.68	28.05	24.03	117.55	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.64	15.76	25.07	30.37	24.39	24.23	20.42	13.27	13.87	12.23
Enterprise Value to Free Cash Flow (EV/FCFF)	6.87	11.54	19.98	42.00	141.47	36.03	22.02	12.15	17.10	8.58
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.51	0.59	0.57	0.59	0.64	0.64	0.69	0.89	1.10
Long-Term Debt to Equity	0.48	0.48	0.51	0.50	0.53	0.55	0.54	0.57	0.72	0.82
Financial Leverage	0.39	0.38	0.43	0.41	0.46	0.47	0.53	0.54	0.61	0.70
Leverage Ratio	1.94	1.92	1.98	1.94	2.11	2.11	2.15	2.15	2.36	2.51
Compound Leverage Factor	1.96	0.48	6.93	1.31	2.28	1.56	1.36	1.43	2.45	2.58
Debt to Total Capital	35.43%	33.77%	37.23%	36.22%	37.12%	39.14%	39.08%	40.65%	47.10%	52.35%
Short-Term Debt to Total Capital	4.40%	2.05%	5.45%	4.50%	3.49%	5.95%	6.41%	7.01%	8.97%	13.46%
Long-Term Debt to Total Capital	31.03%	31.72%	31.78%	31.72%	33.63%	33.19%	32.67%	33.64%	38.13%	38.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.02%	0.02%	-0.05%	-0.07%	-0.07%	0.02%	0.00%	0.00%	-0.02%	0.02%
Common Equity to Total Capital	64.55%	66.21%	62.82%	63.85%	62.95%	60.85%	60.92%	59.35%	52.92%	47.62%
Debt to EBITDA	-3.86	-2.94	-2.81	-2.61	10.05	8.51	6.79	7.21	35.19	-4.12
Net Debt to EBITDA	-3.04	-2.39	-2.39	-2.25	8.49	7.16	5.84	6.25	30.49	-3.60
Long-Term Debt to EBITDA	-3.38	-2.76	-2.40	-2.29	9.11	7.21	5.67	5.97	28.49	-3.06
Debt to NOPAT	-3.41	-2.96	-2.98	-2.79	-30.57	-35.60	-72.82	-42.23	-10.66	-3.47
Net Debt to NOPAT	-2.69	-2.41	-2.54	-2.40	-25.82	-29.98	-62.68	-36.62	-9.24	-3.03
Long-Term Debt to NOPAT	-2.99	-2.78	-2.54	-2.45	-27.70	-30.18	-60.87	-34.95	-8.63	-2.58
Altman Z-Score	1.11	1.75	1.90	2.00	1.70	1.78	1.77	1.51	1.14	0.79
Noncontrolling Interest Sharing Ratio	0.05%	0.02%	-0.02%	-0.04%	-0.04%	0.03%	-0.04%	-0.06%	-0.09%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.50	1.62	1.41	1.51	1.57	1.38	1.43	1.33	1.25	1.10
Quick Ratio	0.82	0.85	0.71	0.76	0.79	0.72	0.71	0.66	0.63	0.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	826	1,240	1,230	1,142	-38	405	444	619	318	916
Operating Cash Flow to CapEx	340.63%	443.75%	-53.85%	315.15%	362.16%	400.00%	73.53%	400.00%	327.91%	170.59%
Free Cash Flow to Firm to Interest Expense	59.03	51.67	61.48	51.90	-2.01	20.26	24.67	36.42	17.64	57.23
Operating Cash Flow to Interest Expense	7.79	5.92	-1.05	4.73	7.05	8.00	1.39	12.24	7.83	5.44
Operating Cash Flow Less CapEx to Interest Expense	5.50	4.58	-3.00	3.23	5.11	6.00	-0.50	9.18	5.44	2.25
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.48	0.46	0.47	0.47	0.53	0.53	0.53	0.54	0.56	0.58
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.21	3.14	2.98	2.98	2.98	3.00	2.94	2.94	2.94	3.09
Fixed Asset Turnover	5.44	5.11	5.10	5.19	5.37	5.08	5.08	4.99	4.97	4.84
Accounts Payable Turnover	6.75	6.64	6.64	6.65	6.96	6.43	6.84	6.75	6.68	6.72
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	113.81	116.11	122.48	122.66	122.29	121.50	124.34	123.99	124.21	118.15
Days Payable Outstanding (DPO)	54.11	55.00	54.97	54.89	52.44	56.72	53.37	54.10	54.67	54.30
Cash Conversion Cycle (CCC)	59.70	61.10	67.50	67.77	69.85	64.78	70.97	69.88	69.54	63.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,179	5,391	5,478	5,509	5,052	5,078	5,057	4,884	4,411	3,806
Invested Capital Turnover	0.67	0.65	0.65	0.66	0.77	0.76	0.75	0.75	0.82	0.85
Increase / (Decrease) in Invested Capital	-1,679	-1,362	-1,231	-994	-127	-313	-421	-625	-641	-1,272
Enterprise Value (EV)	7,548	8,148	10,105	10,144	8,757	9,134	8,638	6,992	7,405	5,637
Market Capitalization	5,982	6,568	8,268	8,341	7,080	7,349	6,839	5,172	5,485	3,773
Book Value per Share	$16.61	$17.73	$16.91	$17.44	$15.94	$15.54	$15.71	$14.76	$12.29	$9.77
Tangible Book Value per Share	($3.89)	($3.63)	($4.28)	($3.79)	($3.35)	($4.01)	($3.67)	($4.26)	($4.85)	($4.34)
Total Capital	5,597	5,756	5,796	5,804	5,361	5,412	5,348	5,163	4,707	4,078
Total Debt	1,983	1,944	2,158	2,102	1,990	2,118	2,090	2,099	2,217	2,135
Total Long-Term Debt	1,737	1,826	1,842	1,841	1,803	1,796	1,747	1,737	1,795	1,586
Net Debt	1,565	1,579	1,840	1,807	1,681	1,784	1,799	1,820	1,921	1,863
Capital Expenditures (CapEx)	32	32	39	33	37	40	34	52	43	51
Debt-free, Cash-free Net Working Capital (DFCFNWC)	471	476	567	615	573	536	624	518	505	434
Debt-free Net Working Capital (DFNWC)	889	841	885	910	882	870	915	797	801	706
Net Working Capital (NWC)	643	723	569	649	695	548	572	435	379	157
Net Nonoperating Expense (NNE)	224	-107	22	63	101	20	6.03	-1.88	172	72
Net Nonoperating Obligations (NNO)	1,565	1,579	1,840	1,807	1,681	1,784	1,799	1,820	1,921	1,863
Total Depreciation and Amortization (D&A)	82	79	84	86	88	85	86	86	89	88
Debt-free, Cash-free Net Working Capital to Revenue	11.65%	12.14%	14.42%	15.63%	14.56%	13.52%	15.84%	13.30%	12.95%	11.44%
Debt-free Net Working Capital to Revenue	21.99%	21.44%	22.51%	23.12%	22.41%	21.94%	23.22%	20.46%	20.54%	18.61%
Net Working Capital to Revenue	15.91%	18.43%	14.47%	16.49%	17.66%	13.82%	14.52%	11.17%	9.72%	4.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($5.01)	($0.06)	($0.09)	$0.41	($1.25)	$0.31	$0.09	($0.02)	($2.46)	($2.09)
Adjusted Weighted Average Basic Shares Outstanding	214.90M	215.50M	214.50M	211.90M	211.80M	212M	207.40M	205.60M	201M	203.20M
Adjusted Diluted Earnings per Share	($5.01)	($0.06)	($0.09)	$0.40	($1.25)	$0.32	$0.09	($0.02)	($2.46)	($2.09)
Adjusted Weighted Average Diluted Shares Outstanding	214.90M	215.50M	214.50M	213.10M	211.80M	212M	208.50M	205.60M	201M	203.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	214.91M	215.36M	212.48M	211.72M	211.86M	207.36M	207.63M	202.71M	198.78M	198.99M
Normalized Net Operating Profit after Tax (NOPAT)	46	46	40	60	54	49	27	50	46	2.10
Normalized NOPAT Margin	4.88%	4.70%	4.08%	5.79%	5.69%	4.84%	2.82%	5.05%	4.78%	0.23%
Pre Tax Income Margin	-131.05%	0.81%	-2.86%	4.47%	-26.40%	5.63%	3.25%	3.46%	-50.26%	-57.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-87.64	1.33	-0.40	3.09	-12.16	3.85	2.72	3.00	-25.56	-31.69
NOPAT to Interest Expense	-60.90	-5.08	-0.07	6.72	-8.69	4.61	1.28	-0.35	-17.97	-22.27
EBIT Less CapEx to Interest Expense	-89.93	0.00	-2.35	1.59	-14.11	1.85	0.83	-0.06	-27.94	-34.88
NOPAT Less CapEx to Interest Expense	-63.19	-6.41	-2.02	5.22	-10.64	2.61	-0.61	-3.40	-20.36	-25.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-12.50%	-10.95%	-10.27%	-10.68%	-51.14%	-87.88%	-128.26%	-66.85%	-30.49%	-13.85%
Augmented Payout Ratio	-44.36%	-26.74%	-24.66%	-25.24%	-119.63%	-315.15%	-291.30%	-232.60%	-128.05%	-41.32%

Frequently Asked Questions About DENTSPLY SIRONA's Financials

When does DENTSPLY SIRONA's financial year end?

According to the most recent income statement we have on file, DENTSPLY SIRONA's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DENTSPLY SIRONA's net income changed over the last 9 years?

DENTSPLY SIRONA's net income appears to be on an upward trend, with a most recent value of -$910 million in 2024, falling from $251.10 million in 2015. The previous period was -$132 million in 2023.

What is DENTSPLY SIRONA's operating income?

DENTSPLY SIRONA's total operating income in 2024 was -$879 million, based on the following breakdown:

Total Gross Profit: $1.96 billion
Total Operating Expenses: $2.84 billion

How has DENTSPLY SIRONA revenue changed over the last 9 years?

Over the last 9 years, DENTSPLY SIRONA's total revenue changed from $2.67 billion in 2015 to $3.79 billion in 2024, a change of 41.8%.

How much debt does DENTSPLY SIRONA have?

DENTSPLY SIRONA's total liabilities were at $3.81 billion at the end of 2024, a 6.5% decrease from 2023, and a 84.6% increase since 2015.

How much cash does DENTSPLY SIRONA have?

In the past 9 years, DENTSPLY SIRONA's cash and equivalents has ranged from $272 million in 2024 to $438 million in 2020, and is currently $272 million as of their latest financial filing in 2024.

How has DENTSPLY SIRONA's book value per share changed over the last 9 years?

Over the last 9 years, DENTSPLY SIRONA's book value per share changed from 16.72 in 2015 to 9.77 in 2024, a change of -41.6%.

Remove Ads

Related Companies

This page (NASDAQ:XRAY) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Financials

Frequently Asked Questions About DENTSPLY SIRONA's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Financials

Annual Income Statements for DENTSPLY SIRONA

Quarterly Income Statements for DENTSPLY SIRONA

Annual Cash Flow Statements for DENTSPLY SIRONA

Quarterly Cash Flow Statements for DENTSPLY SIRONA

Annual Balance Sheets for DENTSPLY SIRONA

Quarterly Balance Sheets for DENTSPLY SIRONA

Annual Metrics and Ratios for DENTSPLY SIRONA

Quarterly Metrics and Ratios for DENTSPLY SIRONA

Frequently Asked Questions About DENTSPLY SIRONA's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools